Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 | Scientific Reports
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
IJMS | Free Full-Text | Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases
Circulating microRNAs as emerging regulators of COVID-19
Frontiers | MicroRNAs as Biomarkers for Animal Health and Welfare in Livestock
Unique microRNA Signals in Plasma Exosomes from Pregnancies Complicated by Preeclampsia | Hypertension
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers | Cell Death & Disease
microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library
IJMS | Free Full-Text | MicroRNAs (miRNAs) in Cardiovascular Complications of Rheumatoid Arthritis (RA): What Is New?
Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction | Clinics
Plasma MicroRNA-133a as a Potential Biomarker for Acute Coronary Syndrome
Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis | Scientific Reports
Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients: Molecular Therapy - Nucleic Acids
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes | Scientific Reports
Time course of microRNAs plasma levels and troponin I in mice with... | Download Scientific Diagram
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
IJMS | Free Full-Text | Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far
MicroRNAs as Potential Predictors of Postoperative AF | ECR Journal
The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism | Scientific Reports
Life | Free Full-Text | Current Knowledge of MicroRNAs (miRNAs) in Acute Coronary Syndrome (ACS): ST-Elevation Myocardial Infarction (STEMI)
Frontiers | Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction
Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
Cells | Free Full-Text | Functional Role of microRNAs in Regulating Cardiomyocyte Death
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
